Report Detail

Pharma & Healthcare COVID-19 Impact on Global Voriconazole, Market Insights and Forecast to 2026

  • RnM4081838
  • |
  • 29 June, 2020
  • |
  • Global
  • |
  • 145 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Study Coverage

  • 1.1 Voriconazole Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Voriconazole Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Voriconazole Market Size Growth Rate by Type
    • 1.4.2 Injection
    • 1.4.3 Freeze-dried Powder
  • 1.5 Market by Application
    • 1.5.1 Global Voriconazole Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Voriconazole Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Voriconazole Industry
      • 1.6.1.1 Voriconazole Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Voriconazole Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Voriconazole Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Voriconazole Market Size Estimates and Forecasts
    • 2.1.1 Global Voriconazole Revenue 2015-2026
    • 2.1.2 Global Voriconazole Sales 2015-2026
  • 2.2 Voriconazole Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Voriconazole Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Voriconazole Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Voriconazole Competitor Landscape by Players

  • 3.1 Voriconazole Sales by Manufacturers
    • 3.1.1 Voriconazole Sales by Manufacturers (2015-2020)
    • 3.1.2 Voriconazole Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Voriconazole Revenue by Manufacturers
    • 3.2.1 Voriconazole Revenue by Manufacturers (2015-2020)
    • 3.2.2 Voriconazole Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Voriconazole Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Voriconazole Revenue in 2019
    • 3.2.5 Global Voriconazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Voriconazole Price by Manufacturers
  • 3.4 Voriconazole Manufacturing Base Distribution, Product Types
    • 3.4.1 Voriconazole Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Voriconazole Product Type
    • 3.4.3 Date of International Manufacturers Enter into Voriconazole Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Voriconazole Market Size by Type (2015-2020)
    • 4.1.1 Global Voriconazole Sales by Type (2015-2020)
    • 4.1.2 Global Voriconazole Revenue by Type (2015-2020)
    • 4.1.3 Voriconazole Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Voriconazole Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Voriconazole Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Voriconazole Revenue Forecast by Type (2021-2026)
    • 4.2.3 Voriconazole Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Voriconazole Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Voriconazole Market Size by Application (2015-2020)
    • 5.1.1 Global Voriconazole Sales by Application (2015-2020)
    • 5.1.2 Global Voriconazole Revenue by Application (2015-2020)
    • 5.1.3 Voriconazole Price by Application (2015-2020)
  • 5.2 Voriconazole Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Voriconazole Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Voriconazole Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Voriconazole Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Voriconazole by Country
    • 6.1.1 North America Voriconazole Sales by Country
    • 6.1.2 North America Voriconazole Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Voriconazole Market Facts & Figures by Type
  • 6.3 North America Voriconazole Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Voriconazole by Country
    • 7.1.1 Europe Voriconazole Sales by Country
    • 7.1.2 Europe Voriconazole Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Voriconazole Market Facts & Figures by Type
  • 7.3 Europe Voriconazole Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Voriconazole by Region
    • 8.1.1 Asia Pacific Voriconazole Sales by Region
    • 8.1.2 Asia Pacific Voriconazole Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Voriconazole Market Facts & Figures by Type
  • 8.3 Asia Pacific Voriconazole Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Voriconazole by Country
    • 9.1.1 Latin America Voriconazole Sales by Country
    • 9.1.2 Latin America Voriconazole Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Voriconazole Market Facts & Figures by Type
  • 9.3 Central & South America Voriconazole Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Voriconazole by Country
    • 10.1.1 Middle East and Africa Voriconazole Sales by Country
    • 10.1.2 Middle East and Africa Voriconazole Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Voriconazole Market Facts & Figures by Type
  • 10.3 Middle East and Africa Voriconazole Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description, Business Overview and Total Revenue
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Voriconazole Products Offered
    • 11.1.5 Pfizer Recent Development
  • 11.2 Teva
    • 11.2.1 Teva Corporation Information
    • 11.2.2 Teva Description, Business Overview and Total Revenue
    • 11.2.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Teva Voriconazole Products Offered
    • 11.2.5 Teva Recent Development
  • 11.3 GeneTech Pharm
    • 11.3.1 GeneTech Pharm Corporation Information
    • 11.3.2 GeneTech Pharm Description, Business Overview and Total Revenue
    • 11.3.3 GeneTech Pharm Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 GeneTech Pharm Voriconazole Products Offered
    • 11.3.5 GeneTech Pharm Recent Development
  • 11.4 Novartis
    • 11.4.1 Novartis Corporation Information
    • 11.4.2 Novartis Description, Business Overview and Total Revenue
    • 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Novartis Voriconazole Products Offered
    • 11.4.5 Novartis Recent Development
  • 11.5 Mylan
    • 11.5.1 Mylan Corporation Information
    • 11.5.2 Mylan Description, Business Overview and Total Revenue
    • 11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Voriconazole Products Offered
    • 11.5.5 Mylan Recent Development
  • 11.6 Squibb
    • 11.6.1 Squibb Corporation Information
    • 11.6.2 Squibb Description, Business Overview and Total Revenue
    • 11.6.3 Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Squibb Voriconazole Products Offered
    • 11.6.5 Squibb Recent Development
  • 11.7 Sandoz
    • 11.7.1 Sandoz Corporation Information
    • 11.7.2 Sandoz Description, Business Overview and Total Revenue
    • 11.7.3 Sandoz Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sandoz Voriconazole Products Offered
    • 11.7.5 Sandoz Recent Development
  • 11.8 Daiichi Sankyo
    • 11.8.1 Daiichi Sankyo Corporation Information
    • 11.8.2 Daiichi Sankyo Description, Business Overview and Total Revenue
    • 11.8.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Daiichi Sankyo Voriconazole Products Offered
    • 11.8.5 Daiichi Sankyo Recent Development
  • 11.9 GSK
    • 11.9.1 GSK Corporation Information
    • 11.9.2 GSK Description, Business Overview and Total Revenue
    • 11.9.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 GSK Voriconazole Products Offered
    • 11.9.5 GSK Recent Development
  • 11.10 Cilag AG
    • 11.10.1 Cilag AG Corporation Information
    • 11.10.2 Cilag AG Description, Business Overview and Total Revenue
    • 11.10.3 Cilag AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Cilag AG Voriconazole Products Offered
    • 11.10.5 Cilag AG Recent Development
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description, Business Overview and Total Revenue
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer Voriconazole Products Offered
    • 11.1.5 Pfizer Recent Development
  • 11.12 Abbott
    • 11.12.1 Abbott Corporation Information
    • 11.12.2 Abbott Description, Business Overview and Total Revenue
    • 11.12.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Abbott Products Offered
    • 11.12.5 Abbott Recent Development
  • 11.13 Takeda
    • 11.13.1 Takeda Corporation Information
    • 11.13.2 Takeda Description, Business Overview and Total Revenue
    • 11.13.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Takeda Products Offered
    • 11.13.5 Takeda Recent Development
  • 11.14 Sichuan Beauty Sport Huakang Pharmaceutical
    • 11.14.1 Sichuan Beauty Sport Huakang Pharmaceutical Corporation Information
    • 11.14.2 Sichuan Beauty Sport Huakang Pharmaceutical Description, Business Overview and Total Revenue
    • 11.14.3 Sichuan Beauty Sport Huakang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Sichuan Beauty Sport Huakang Pharmaceutical Products Offered
    • 11.14.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
  • 11.15 Jincheng HEALTH Pharmaceutical
    • 11.15.1 Jincheng HEALTH Pharmaceutical Corporation Information
    • 11.15.2 Jincheng HEALTH Pharmaceutical Description, Business Overview and Total Revenue
    • 11.15.3 Jincheng HEALTH Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Jincheng HEALTH Pharmaceutical Products Offered
    • 11.15.5 Jincheng HEALTH Pharmaceutical Recent Development
  • 11.16 Ebang Pharmaceutical
    • 11.16.1 Ebang Pharmaceutical Corporation Information
    • 11.16.2 Ebang Pharmaceutical Description, Business Overview and Total Revenue
    • 11.16.3 Ebang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Ebang Pharmaceutical Products Offered
    • 11.16.5 Ebang Pharmaceutical Recent Development
  • 11.17 Aditya Pharma
    • 11.17.1 Aditya Pharma Corporation Information
    • 11.17.2 Aditya Pharma Description, Business Overview and Total Revenue
    • 11.17.3 Aditya Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Aditya Pharma Products Offered
    • 11.17.5 Aditya Pharma Recent Development
  • 11.18 Taj Pharmaceuticals
    • 11.18.1 Taj Pharmaceuticals Corporation Information
    • 11.18.2 Taj Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.18.3 Taj Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Taj Pharmaceuticals Products Offered
    • 11.18.5 Taj Pharmaceuticals Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Voriconazole Market Estimates and Projections by Region
    • 12.1.1 Global Voriconazole Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Voriconazole Revenue Forecast by Regions 2021-2026
  • 12.2 North America Voriconazole Market Size Forecast (2021-2026)
    • 12.2.1 North America: Voriconazole Sales Forecast (2021-2026)
    • 12.2.2 North America: Voriconazole Revenue Forecast (2021-2026)
    • 12.2.3 North America: Voriconazole Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Voriconazole Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Voriconazole Sales Forecast (2021-2026)
    • 12.3.2 Europe: Voriconazole Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Voriconazole Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Voriconazole Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Voriconazole Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Voriconazole Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Voriconazole Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Voriconazole Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Voriconazole Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Voriconazole Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Voriconazole Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Voriconazole Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Voriconazole Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Voriconazole Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Voriconazole Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Voriconazole Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Voriconazole Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Voriconazole market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Voriconazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Voriconazole market is segmented into
    Injection
    Freeze-dried Powder

    Segment by Application, the Voriconazole market is segmented into
    Hospital
    Clinic
    Other

    Regional and Country-level Analysis
    The Voriconazole market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Voriconazole market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Voriconazole Market Share Analysis
    Voriconazole market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Voriconazole business, the date to enter into the Voriconazole market, Voriconazole product introduction, recent developments, etc.
    The major vendors covered:
    Pfizer
    Teva
    GeneTech Pharm
    Novartis
    Mylan
    Squibb
    Sandoz
    Daiichi Sankyo
    GSK
    Cilag AG
    Macherey-Nagel GmbH
    Abbott
    Takeda
    Sichuan Beauty Sport Huakang Pharmaceutical
    Jincheng HEALTH Pharmaceutical
    Ebang Pharmaceutical
    Aditya Pharma
    Taj Pharmaceuticals


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Voriconazole. Industry analysis & Market Report on COVID-19 Impact on Global Voriconazole is a syndicated market report, published as COVID-19 Impact on Global Voriconazole, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Voriconazole market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,102.96
    4,654.44
    6,205.92
    3,449.64
    5,174.47
    6,899.29
    419,156.40
    628,734.60
    838,312.80
    292,447.74
    438,671.61
    584,895.48
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report